What to watch: New launch in US bodes well for Lupin

Shares of pharma major Lupin will remain in focus, as the company on Monday said it has launched its testosterone topical solution in the United States. The company has launched Testosterone Topical Solution, 30 mg per actuation, in the US after receiving approval from the United States Food and Drug Administration, Lupin said. The company’s product is the generic version of Eli Lilly and the company’s Axiron topical solution, 30 mg per actuation, it added.